Less Aggressive Chemoradiation for MIBC Tested in Noncystectomy Patients
A study tested a less aggressive chemoradiation protocol in patients with muscle-invasive bladder cancer (MIBC) unfit for surgery due to older age or comorbidities.
A study tested a less aggressive chemoradiation protocol in patients with muscle-invasive bladder cancer (MIBC) unfit for surgery due to older age or comorbidities.
Report highlights advances such as approval of 14 new anticancer therapeutics, expansion of use of 12 previously approved therapeutics
Adding ipilimumab to treatment with nivolumab does not provide a clinically meaningful benefit in patients with certain cancers, a meta-analysis suggests.
Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.
The burden of administrative tasks required to pay for cancer care is associated with nonadherence to care, a new study suggests.
Investigators reviewed the latest studies examining the association between BCG administration and the risk of Alzheimer disease and other dementia in patients with bladder cancer.
Cancer death rates have declined in the United States in recent years, but the declines are greater in urban than in rural areas, data suggest.
Adding durvalumab to standard treatment for resectable, muscle-invasive urothelial carcinoma produces promising outcomes, according to researchers.
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
PENK methylation test has high sensitivity and specificity for detecting bladder cancer in patients with hematuria